How could Veracyte's financial and operational status affect San Francisco?
Veracyte's financial challenges may impact San Francisco's local economy Veracyte, a global diagnostics company headquartered in San Francisco, provides lab testing services across the United States. Furthermore, its stock has declined over the past three months, and its Return on Equity (ROE) is considered weak compared to the industry average. If these financial and operational pressures intensify, they could potentially impact the local employment and tax revenue base of San Francisco.
- Effect
- Mild negative
- How direct
- Stated in the reporting
- When
- Over the long term
- The story
- Gone quiet
How it reaches San Francisco
-
Veracyte is a global diagnostics company that provides advanced genomic tests for various conditions, including cancer. Based on trailing twelve months to March 2025, the company reported a Return on Equity (ROE) of 2.8%, calculated from US$33 million in net profit against US$1.2 billion in shareholders' equity.
The full event2independent outlets -
Veracyte is headquartered in San Francisco, California, making it a significant business entity within the city's economy. The company's operations include providing lab testing services across the US.
1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- Zacks Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today For most investors, how much a stock's price changes over time is important. This factor can impact your investmeAug 29
-
consolidated city and county in California, United States
Everything about San Francisco
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- Veracyte is headquartered in San Francisco, CA.Zacks
- The sale of Veracyte SAS manufacturing business creates a temporary revenue headwind.Zacks
- Veracyte's stock is down 21% over the past three months.Simply Wall St.
- Veracyte's Return on Equity (ROE) is 2.8%, compared to the industry average of 17%.Simply Wall St.
Why it matters
As a major corporate entity, Veracyte's operational stability and financial health are tied to the local economy of San Francisco. If the company faces sustained revenue headwinds or operational risks, it could potentially lead to changes in its staffing levels or investment within the city.
This situation is part of a broader context where the financial performance of large, specialized companies influences municipal finances. The reports note that the adverse impacts of macroeconomic challenges and an intense competitive landscape may pose operational risks to Veracyte.
What we don't know yet
- How significant is Veracyte's employment footprint within San Francisco?
- What is the extent of Veracyte's tax contribution to San Francisco?
Is this still moving?
- Reports
- 7
- Developments
- 5
- Repetition
- 71%
What would change this answer
Reporting
- ZacksAug 29
- Simply Wall St.Jul 31
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.